Magnetite Nanoparticle Development for Targeted Anti-Inflammatory Drug Delivery in Rheumatoid Arthritis
Introduction: About one percent of the world's population suffers with rheumatoid arthritis, a degenerative inflammatory disease that gradually destroys joints and causes severe pain and impairment. Because of their biocompatibility, controlled drug release capabilities, and superparamagnetic characteristics, magnetite nanoparticles have become attractive candidates for targeted medication delivery. In order to improve therapy outcomes in RA, this study seeks to create and describe magnetite nanoparticles that can deliver anti-inflammatory medicines to inflamed joints.
Authors
- Vishwa S. Padole (ORCID: https://orcid.org/0000-0002-0150-8311)
- Mohammed Saifuddin Khalid (ORCID: https://orcid.org/0000-0002-3163-3949)
- J.B. Veeramalini
- Nandi J. Reddy
- Dil Prasad Subba
- Ujwala Panditrao Mahale
- Ashish Ambadas Sabale
- Naresh S. Halke
Institutions
- Vel Tech Rangarajan Dr. Sagunthala R&D Institute of Science and Technology (IN)
- Sri Devaraj Urs Medical College (IN)
- Sant Gadge Baba Amravati University (IN)
- Krishi Vigyan Kendra, Latur (IN)
- ACPM Dental College and Hospital (IN)
- Sri Devaraj Urs Academy of Higher Education and Research (IN)
- Raisoni Group of Institutions (IN)
- Centurion University of Technology and Management (IN)
- Sri Siddhartha Medical College (IN)
- Sharda University (IN)
- National Institute of Technology Meghalaya (IN)
Publication Details
- Journal
- Cuestiones de Fisioterapia
- Published
- 2025-02-19
- DOI
- https://doi.org/10.48047/g826qp16
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00